Spots Global Cancer Trial Database for Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients
Official Title: Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients
Study ID: NCT04340024
Interventions
Study Description
Brief Summary: Patients with cancers that are sensitive to radiotherapy treatment and/or patients who have experienced severe acute/ late side effects to radiotherapy will be recruited to the study. Blood and/or matched tumour-normal tissue pairs will be collected. Blood and/or tissue samples will be processed and studied for genetic and biochemical markers that have potential to be used for predicting sensitivity to radiation.
Detailed Description:
Eligibility
Minimum Age: 21 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
National Cancer Center Singapore, Singapore, , Singapore
Contact Details
Name: Melvin Chua, MD
Affiliation: National Cancer Centre, Singapore
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
